Acamprosate calcium

Suppliers

Names

[ Name ]:
Acamprosate calcium

[Synonym ]:
Campral
Acamprosate calcium
MFCD00886588
calcium acetylhomotaurinate
Calciumbis[3-(acetylamino)propan-1-sulfonat]
CA-Aota
Alcomed
3-(Acetylamino)-1-propanesulfonic Acid Calcium Salt (2:1)
Sobriol
1-Propanesulfonic acid, 3-(acetylamino)-, calcium salt (2:1)
Calcium bis(3-acetamido-1-propanesulfonate)
Calcium Bisacetyl Homotaurine
bis[3-(acétylamino)propane-1-sulfonate] de calcium
Aotal
calcium acetyl homotaurinate
calcium bis[3-(acetylamino)propane-1-sulfonate]
calcium,3-acetamidopropane-1-sulfonate
EINECS 278-665-3
Calcium bis(3-acetamidopropane-1-sulfonate)
Acamprosate (calcium)

Chemical & Physical Properties

[ Melting Point ]:
>300ºC

[ Molecular Formula ]:
C₅H₁₀NO₄S_.1/₂Ca

[ Molecular Weight ]:
200.24

[ PSA ]:
189.36000

[ LogP ]:
1.05900

[ Storage condition ]:
Room temp

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
26-36/37/39-36

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2924199090

Customs

[ HS Code ]: 2924199090

[ Summary ]:
2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.

Sci. Rep. 5 , 7608, (2015)

Alzheimer disease (AD) represents a major medical problem where mono-therapeutic interventions demonstrated only a limited efficacy so far. We explored the possibility of developing a combinational th...

Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat.

Neuropsychopharmacology 39(11) , 2601-10, (2014)

Since its discovery, the nociceptin/orphanin FQ (N/OFQ)-NOP receptor system has been extensively investigated as a promising target to treat alcoholism. Encouraging results obtained with the endogenou...

Acamprosate calcium as augmentation therapy for anxiety disorders.

Ann. Pharmacother. 44 , 1930-2, (2010)

Glutamate is a major excitatory neurotransmitter, while γ-aminobutyric acid (GABA) is a predominant inhibitory neurotransmitter in the central nervous system. This GABA-glutamate imbalance is thought ...